{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["epidemiology", "glycosides", "immune response", "inflammatory response", "oxidative stress", "signal transduction", "ulcerative colitis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37446872", "DateCompleted": {"Year": "2023", "Month": "07", "Day": "17"}, "DateRevised": {"Year": "2023", "Month": "07", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "04"}], "Language": ["eng"], "ELocationID": ["5210", "10.3390/molecules28135210"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "13", "PubDate": {"Year": "2023", "Month": "Jul", "Day": "04"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Glycosides as Potential Medicinal Components for Ulcerative Colitis: A Review.", "Abstract": {"AbstractText": ["Ulcerative colitis (UC) is a chronic, non-specific disease of unknown etiology. The disease develops mainly in the rectum or colon, and the main clinical symptoms include abdominal pain, diarrhea, and purulent bloody stools, with a wide variation in severity. The specific causative factors and pathogenesis of the disease are not yet clear, but most scholars believe that the disease is caused by the interaction of genetic, environmental, infectious, immune, and intestinal flora factors. As for the treatment of UC, medications are commonly used in clinical practice, mainly including aminosalicylates, glucocorticoids, and immunosuppressive drugs. However, due to the many complications associated with conventional drug therapy and the tendency for UC to recur, there is an urgent need to discover new, safer, and more effective drugs. Natural compounds with biodiversity and chemical structure diversity from medicinal plants are the most reliable source for the development of new drug precursors. Evidence suggests that glycosides may reduce the development and progression of UC by modulating anti-inflammatory responses, inhibiting oxidative stress, suppressing abnormal immune responses, and regulating signal transduction. In this manuscript, we provide a review of the epidemiology of UC and the available drugs for disease prevention and treatment. In addition, we demonstrate the protective or therapeutic role of glycosides in UC and describe the possible mechanisms of action to provide a theoretical basis for preclinical studies in drug development."]}, "AuthorList": [{"Identifier": ["0000-0002-7681-847X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Science, Ningxia Medical University, Yinchuan 750004, China."}], "LastName": "Niu", "ForeName": "Yating", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong Academy of Chinese Medicine, Jinan 250014, China."}], "LastName": "Zhang", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong Academy of Chinese Medicine, Jinan 250014, China."}], "LastName": "Shi", "ForeName": "Dianhua", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China."}], "LastName": "Zang", "ForeName": "Weibiao", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Science, Ningxia Medical University, Yinchuan 750004, China."}], "LastName": "Niu", "ForeName": "Jianguo", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunosuppressive Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Colitis, Ulcerative"}, {"QualifierName": ["therapeutic use", "pharmacology"], "DescriptorName": "Glycosides"}, {"QualifierName": [], "DescriptorName": "Colon"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Immunosuppressive Agents"}, {"QualifierName": [], "DescriptorName": "Rectum"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ungaro R., Mehandru S., Allen P.B., Peyrin-Biroulet L., Colombel J.-F. Ulcerative colitis. Lancet. 2017;389:1756\u20131770. doi: 10.1016/S0140-6736(16)32126-2.", "ArticleIdList": ["10.1016/S0140-6736(16)32126-2", "PMC6487890", "27914657"]}, {"Citation": "H\u00f8ivik M.L., Moum B., Solberg I.C., Henriksen M., Cvancarova M., Bernklev T. IBSEN Group Work disability in inflammatory bowel disease patients 10 years after disease onset: Results from the IBSEN Study. Gut. 2013;62:368\u2013375. doi: 10.1136/gutjnl-2012-302311.", "ArticleIdList": ["10.1136/gutjnl-2012-302311", "22717453"]}, {"Citation": "Conrad K., Roggenbuck D., Laass M.W. Diagnosis and classification of ulcerative colitis. Autoimmun. Rev. 2014;13:463\u2013466. doi: 10.1016/j.autrev.2014.01.028.", "ArticleIdList": ["10.1016/j.autrev.2014.01.028", "24424198"]}, {"Citation": "Anzai H., Hata K., Kishikawa J., Ishii H., Nishikawa T., Tanaka T., Tanaka J., Kiyomatsu T., Kawai K., Nozawa H., et al. Clinical pattern and progression of ulcerative proctitis in the Japanese population: A retrospective study of incidence and risk factors influencing progression. Color. Dis. 2016;18:O97\u2013O102. doi: 10.1111/codi.13237.", "ArticleIdList": ["10.1111/codi.13237", "26663677"]}, {"Citation": "Wu K., Zhang Q., Sha S., Xu B., Liang S. Prevalence of colorectal cancer in patients with ulcerative colitis: A retrospective, monocenter study in China. J. Cancer Res. Ther. 2015;11:899\u2013903. doi: 10.4103/0973-1482.143345.", "ArticleIdList": ["10.4103/0973-1482.143345", "26881538"]}, {"Citation": "Rosenzwajg M., Lorenzon R., Cacoub P., Pham H.P., Pitoiset F., El Soufi K., Ribet C., Bernard C., Aractingi S., Banneville B., et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Ann. Rheum. Dis. 2019;78:209\u2013217. doi: 10.1136/annrheumdis-2018-214229.", "ArticleIdList": ["10.1136/annrheumdis-2018-214229", "30472651"]}, {"Citation": "Park J.H., Peyrin-Biroulet L., Eisenhut M., Shin J.I. IBD immunopathogenesis: A comprehensive review of inflammatory molecules. Autoimmun. Rev. 2017;16:416\u2013426. doi: 10.1016/j.autrev.2017.02.013.", "ArticleIdList": ["10.1016/j.autrev.2017.02.013", "28212924"]}, {"Citation": "Park S.C., Jeen Y.T. Anti-integrin therapy for inflammatory bowel disease. World J. Gastroenterol. 2018;24:1868\u20131880. doi: 10.3748/wjg.v24.i17.1868.", "ArticleIdList": ["10.3748/wjg.v24.i17.1868", "PMC5937204", "29740202"]}, {"Citation": "Nielsen O.H., Bjerrum J.T., Herfarth H., Rogler G. Recent Advances Using Immunomodulators for Inflammatory Bowel Disease. J. Clin. Pharmacol. 2013;53:575\u2013588. doi: 10.1002/jcph.2.", "ArticleIdList": ["10.1002/jcph.2", "23408468"]}, {"Citation": "Poitras P., Gougeon A., Binn M., Bouin M. Extra digestive manifestations of irritable bowel syndrome: Intolerance to drugs? Dig. Dis. Sci. 2008;53:2168\u20132176. doi: 10.1007/s10620-007-0123-8.", "ArticleIdList": ["10.1007/s10620-007-0123-8", "18095162"]}, {"Citation": "Triantafillidis J.K., Merikas E., Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des. Dev. Ther. 2011;5:185\u2013210. doi: 10.2147/DDDT.S11290.", "ArticleIdList": ["10.2147/DDDT.S11290", "PMC3084301", "21552489"]}, {"Citation": "Xue J.-C., Yuan S., Meng H., Hou X.-T., Li J., Zhang H.-M., Chen L.-L., Zhang C.-H., Zhang Q.-G. The role and mechanism of flavonoid herbal natural products in ulcerative colitis. Biomed. Pharmacother. 2023;158:114086. doi: 10.1016/j.biopha.2022.114086.", "ArticleIdList": ["10.1016/j.biopha.2022.114086", "36502751"]}, {"Citation": "Araruna M.E., Serafim C., Alves J\u00fanior E., Hiruma-Lima C., Diniz M., Batista L. Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010\u20132020): A Review. Molecules. 2020;25:5430. doi: 10.3390/molecules25225430.", "ArticleIdList": ["10.3390/molecules25225430", "PMC7699610", "33233487"]}, {"Citation": "Santos J.A.M., Santos C.L.A.A., Freitas Filho J.R., Menezes P.H., Freitas J.C.R. Polyacetylene Glycosides: Isolation, Biological Activities and Synthesis. Chem. Rec. 2022;22:e202100176. doi: 10.1002/tcr.202100176.", "ArticleIdList": ["10.1002/tcr.202100176", "34665514"]}, {"Citation": "Tian X.Y., Li M.X., Lin T., Qiu Y., Zhu Y.T., Li X.L., Tao W.D., Wang P., Ren X.X., Chen L.P. A review on the structure and pharmaco-logical activity of phenylethanoid glycosides. Eur. J. Med. Chem. 2021;209:112563. doi: 10.1016/j.ejmech.2020.112563.", "ArticleIdList": ["10.1016/j.ejmech.2020.112563", "33038797"]}, {"Citation": "Khan H., Pervaiz A., Intagliata S., Das N., Venkata K.C.N., Atanasov A.G., Najda A., Nabavi S.M., Wang D., Pittal\u00e0 V., et al. The analgesic potential of glycosides derived from medicinal plants. DARU J. Pharm. Sci. 2020;28:387\u2013401. doi: 10.1007/s40199-019-00319-7.", "ArticleIdList": ["10.1007/s40199-019-00319-7", "PMC7214601", "32060737"]}, {"Citation": "Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., Benchimol E.I., Panaccione R., Ghosh S., Barkema H.W., et al. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review. Gastroenterology. 2012;142:46\u201354.e42; quiz e30. doi: 10.1053/j.gastro.2011.10.001.", "ArticleIdList": ["10.1053/j.gastro.2011.10.001", "22001864"]}, {"Citation": "Torres J., Billioud V., Sachar D.B., Peyrin-Biroulet L., Colombel J.-F. Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence. Inflamm. Bowel Dis. 2012;18:1356\u20131363. doi: 10.1002/ibd.22839.", "ArticleIdList": ["10.1002/ibd.22839", "22162423"]}, {"Citation": "Kaplan G.G. The global burden of IBD: From 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 2015;12:720\u2013727. doi: 10.1038/nrgastro.2015.150.", "ArticleIdList": ["10.1038/nrgastro.2015.150", "26323879"]}, {"Citation": "Du L., Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol. Clin. N. Am. 2020;49:643\u2013654. doi: 10.1016/j.gtc.2020.07.005.", "ArticleIdList": ["10.1016/j.gtc.2020.07.005", "33121686"]}, {"Citation": "Cohen R.D., Yu A.P., Wu E.Q., Xie J., Mulani P.M., Chao J. Systematic review: The costs of ulcerative colitis in Western countries. Aliment. Pharmacol. Ther. 2010;31:693\u2013707. doi: 10.1111/j.1365-2036.2010.04234.x.", "ArticleIdList": ["10.1111/j.1365-2036.2010.04234.x", "20064142"]}, {"Citation": "Neurath M.F. Current and emerging therapeutic targets for IBD. Nat. Rev. Gastroenterol. Hepatol. 2017;14:269\u2013278. doi: 10.1038/nrgastro.2016.208.", "ArticleIdList": ["10.1038/nrgastro.2016.208", "28144028"]}, {"Citation": "Schroeder K.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N. Engl. J. Med. 1987;317:1625\u20131629. doi: 10.1056/NEJM198712243172603.", "ArticleIdList": ["10.1056/NEJM198712243172603", "3317057"]}, {"Citation": "Travis S.P.L., Danese S., Kupcinskas L., Alexeeva O., D\u2019Haens G., Gibson P.R., Moro L., Jones R., Ballard E.D., Masure J., et al. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: Results from the randomised CORE II study. Gut. 2014;63:433\u2013441. doi: 10.1136/gutjnl-2012-304258.", "ArticleIdList": ["10.1136/gutjnl-2012-304258", "PMC3933176", "23436336"]}, {"Citation": "Dami\u00e3o A.O.M.C., De Azevedo M.F.C., Carlos A.D.S., Wada M.Y., Silva T.V.M., Feitosa F.D.C. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review. World J. Gastroenterol. 2019;25:1142\u20131157. doi: 10.3748/wjg.v25.i9.1142.", "ArticleIdList": ["10.3748/wjg.v25.i9.1142", "PMC6406187", "30863001"]}, {"Citation": "Sultan K.S., Berkowitz J.C., Khan S. Combination therapy for inflammatory bowel disease. World J. Gastrointest. Pharmacol. Ther. 2017;8:103\u2013113. doi: 10.4292/wjgpt.v8.i2.103.", "ArticleIdList": ["10.4292/wjgpt.v8.i2.103", "PMC5421108", "28533919"]}, {"Citation": "Broekman M.M.T.J., Coenen M.J.H., van Marrewijk C.J., Wanten G.J.A., Wong D.R., Verbeek A.L.M., TOPIC Recruitment Team More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing. Inflamm. Bowel Dis. 2017;23:1873\u20131881. doi: 10.1097/MIB.0000000000001163.", "ArticleIdList": ["10.1097/MIB.0000000000001163", "PMC5598908", "28644183"]}, {"Citation": "Moayyedi P., Surette M.G., Kim P.T., Libertucci J., Wolfe M., Onischi C., Armstrong D., Marshall J.K., Kassam Z., Reinisch W., et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015;149:102\u2013109.e6. doi: 10.1053/j.gastro.2015.04.001.", "ArticleIdList": ["10.1053/j.gastro.2015.04.001", "25857665"]}, {"Citation": "Meyers S., Shih J., Neher J.O., Safranek S. Clinical Inquiries: How effective and safe is fecal microbial transplant in preventing C difficile recurrence? J. Fam. Pract. 2018;67:386\u2013388.", "ArticleIdList": ["29879241"]}, {"Citation": "Cottone M., Kohn A., Daperno M., Armuzzi A., Guidi L., D\u2019Inca R., Bossa F., Angelucci E., Biancone L., Gionchetti P., et al. Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti\u2013Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease. Clin. Gastroenterol. Hepatol. 2011;9:30\u201335. doi: 10.1016/j.cgh.2010.09.026.", "ArticleIdList": ["10.1016/j.cgh.2010.09.026", "20951835"]}, {"Citation": "Suzuki Y., Motoya S., Hanai H., Hibi T., Nakamura S., Lazar A., Robinson A.M., Skup M., Mostafa N.M., Huang B., et al. Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis. J. Gastroenterol. 2017;52:1031\u20131040. doi: 10.1007/s00535-017-1325-2.", "ArticleIdList": ["10.1007/s00535-017-1325-2", "PMC5569655", "28321512"]}, {"Citation": "Rutgeerts P., Feagan B.G., Marano C.W., Padgett L., Strauss R., Johanns J., PURSUIT-IV Study Group Randomised clinical trial: A placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis. Aliment. Pharmacol. Ther. 2015;42:504\u2013514. doi: 10.1111/apt.13291.", "ArticleIdList": ["10.1111/apt.13291", "PMC4755132", "26119226"]}, {"Citation": "Wolfender J.-L., Litaudon M., Touboul D., Queiroz E.F. Innovative omics-based approaches for prioritisation and targeted isolation of natural products\u2013new strategies for drug discovery. Nat. Prod. Rep. 2019;36:855\u2013868. doi: 10.1039/C9NP00004F.", "ArticleIdList": ["10.1039/C9NP00004F", "31073562"]}, {"Citation": "Khan H., Saeedi M., Nabavi S.M., Mubarak M.S., Bishayee A. Glycosides from Medicinal Plants as Potential Anticancer Agents: Emerging Trends Towards Future Drugs. Curr. Med. Chem. 2019;26:2389\u20132406. doi: 10.2174/0929867325666180403145137.", "ArticleIdList": ["10.2174/0929867325666180403145137", "29611474"]}, {"Citation": "Johnson J.B., Mani J.S., Broszczak D., Prasad S.S., Ekanayake C.P., Strappe P., Valeris P., Naiker M. Hitting the sweet spot: A systematic review of the bioactivity and health benefits of phenolic glycosides from medicinally used plants. Phytother. Res. 2021;35:3484\u20133508. doi: 10.1002/ptr.7042.", "ArticleIdList": ["10.1002/ptr.7042", "33615599"]}, {"Citation": "Grubb C.D., Zipp B.J., Ludwig-M\u00fcller J., Masuno M.N., Molinski T.F., Abel S. Arabidopsis glucosyltransferase UGT74B1 functions in glucosinolate biosynthesis and auxin homeostasis. Plant J. 2004;40:893\u2013908. doi: 10.1111/j.1365-313X.2004.02261.x.", "ArticleIdList": ["10.1111/j.1365-313X.2004.02261.x", "15584955"]}, {"Citation": "Wang J., Ma X.-M., Kojima M., Sakakibara H., Hou B.-K. N-Glucosyltransferase UGT76C2 is Involved in Cytokinin Homeostasis and Cytokinin Response in Arabidopsis thaliana. Plant Cell Physiol. 2011;52:2200\u20132213. doi: 10.1093/pcp/pcr152.", "ArticleIdList": ["10.1093/pcp/pcr152", "22051886"]}, {"Citation": "Hirade Y., Kotoku N., Terasaka K., Saijo-Hamano Y., Fukumoto A., Mizukami H. Identification and functional analysis of 2-hydroxyflavanoneC-glucosyltransferase in soybean (Glycine max) FEBS Lett. 2015;589:1778\u20131786. doi: 10.1016/j.febslet.2015.05.010.", "ArticleIdList": ["10.1016/j.febslet.2015.05.010", "25979175"]}, {"Citation": "Qian Z.M., Wan J.B., Zhang Q.W., Li S.P. Simultaneous determination of nucleobases, nucleosides and saponins in Panax noto-ginseng using multiple columns high performance liquid chromatography. J. Pharm. Biomed. Anal. 2008;48:1361\u20131367. doi: 10.1016/j.jpba.2008.09.038.", "ArticleIdList": ["10.1016/j.jpba.2008.09.038", "18995982"]}, {"Citation": "Zhao Y.-Z., Zhang Y.-Y., Han H., Fan R.-P., Hu Y., Zhong L., Kou J.-P., Yu B.-Y. Advances in the antitumor activities and mechanisms of action of steroidal saponins. Chin. J. Nat. Med. 2018;16:732\u2013748. doi: 10.1016/S1875-5364(18)30113-4.", "ArticleIdList": ["10.1016/S1875-5364(18)30113-4", "30322607"]}, {"Citation": "Xue H., Chen K.X., Zhang L.Q., Li Y.M. Review of the Ethnopharmacology, Phytochemistry, and Pharmacology of the Ge-nus Veronica. Am. J. Chin. Med. 2019;47:1193\u20131221. doi: 10.1142/S0192415X19500617.", "ArticleIdList": ["10.1142/S0192415X19500617", "31488038"]}, {"Citation": "Zhang L., Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol. Ther. 2020;207:107452. doi: 10.1016/j.pharmthera.2019.107452.", "ArticleIdList": ["10.1016/j.pharmthera.2019.107452", "31836457"]}, {"Citation": "Li Y.C., Qiao J.Y., Wang B.Y., Bai M., Shen J.D., Cheng Y.X. Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways. Nutrients. 2018;10:1024. doi: 10.3390/nu10081024.", "ArticleIdList": ["10.3390/nu10081024", "PMC6116094", "30081580"]}, {"Citation": "Zhang J., Wang F., Wang H., Wang Y., Wu Y., Xu H., Su C. Paeoniflorin inhibits proliferation of endometrial cancer cells via acti-vating MAPK and NF-\u03baB signaling pathways. Exp. Ther. Med. 2017;14:5445\u20135451.", "ArticleIdList": ["PMC5740769", "29285074"]}, {"Citation": "Zhao Y., Zhou G., Wang J., Jia L., Zhang P., Li R., Shan L., Liu B., Song X., Liu S., et al. Paeoniflorin protects against ANIT-induced cholestasis by ameliorating oxidative stress in rats. Food Chem. Toxicol. 2013;58:242\u2013248. doi: 10.1016/j.fct.2013.04.030.", "ArticleIdList": ["10.1016/j.fct.2013.04.030", "23623840"]}, {"Citation": "Tu J., Guo Y., Hong W., Fang Y., Han D., Zhang P., Wang X., K\u00f6rner H., Wei W. The Regulatory Effects of Paeoniflorin and Its Derivative Paeoniflorin-6\u2032-O-Benzene Sulfonate CP-25 on Inflammation and Immune Diseases. Front. Pharmacol. 2019;10:57. doi: 10.3389/fphar.2019.00057.", "ArticleIdList": ["10.3389/fphar.2019.00057", "PMC6370653", "30804784"]}, {"Citation": "Lv T., Shen L., Yang L., Diao W., Yang Z., Zhang Y., Yu S., Li Y. Polydatin ameliorates dextran sulfate sodium-induced colitis by decreasing oxidative stress and apoptosis partially via Sonic hedgehog signaling pathway. Int. Immunopharmacol. 2018;64:256\u2013263. doi: 10.1016/j.intimp.2018.09.009.", "ArticleIdList": ["10.1016/j.intimp.2018.09.009", "30218952"]}, {"Citation": "Li J., Huang S., Huang W., Wang W., Wen G., Gao L., Fu X., Wang M., Liang W., Kwan H.Y., et al. Paeoniflorin ameliorates interferon-alpha-induced neuroinflammation and depressive-like behaviors in mice. Oncotarget. 2017;8:8264\u20138282. doi: 10.18632/oncotarget.14160.", "ArticleIdList": ["10.18632/oncotarget.14160", "PMC5352399", "28030814"]}, {"Citation": "Kong X., Leng D., Liang G., Zheng H., Wang Q., Shen Y., Lu G., Zhang H., Shi D., Liu W. Paeoniflorin augments systemic Candida albicans infection through inhibiting Th1 and Th17 cell expression in a mouse model. Int. Immunopharmacol. 2018;60:76\u201383. doi: 10.1016/j.intimp.2018.03.001.", "ArticleIdList": ["10.1016/j.intimp.2018.03.001", "29705532"]}, {"Citation": "Chen G., Yang Z., Wen D., Guo J., Xiong Q., Li P., Zhao L., Wang J., Wu C., Dong L. Polydatin has anti-inflammatory and antioxidant effects in LPS-induced macrophages and improves DSS-induced mice colitis. Immun. Inflamm. Dis. 2021;9:959\u2013970. doi: 10.1002/iid3.455.", "ArticleIdList": ["10.1002/iid3.455", "PMC8342204", "34010516"]}, {"Citation": "Wang Y., Zhou Y., Lin H., Chen H., Wang S. Paeoniflorin Inhibits the Proliferation and Metastasis of Ulcerative Colitis-Associated Colon Cancer by Targeting EGFL7. J. Oncol. 2022;2022:7498771. doi: 10.1155/2022/7498771.", "ArticleIdList": ["10.1155/2022/7498771", "PMC9441402", "36072982"]}, {"Citation": "Hasegawa H. Proof of the mysterious efficacy of ginseng: Basic and clinical trials: Metabolic activation of ginsenoside: Degly-cosylation by intestinal bacteria and esterification with fatty acid. J. Pharmacol. Sci. 2004;95:153\u2013157. doi: 10.1254/jphs.FMJ04001X4.", "ArticleIdList": ["10.1254/jphs.FMJ04001X4", "15215638"]}, {"Citation": "Spanogiannopoulos P., Bess E.N., Carmody R.N., Turnbaugh P.J. The microbial pharmacists within us: A metagenomic view of xenobiotic metabolism. Nat. Rev. Microbiol. 2016;14:273\u2013287. doi: 10.1038/nrmicro.2016.17.", "ArticleIdList": ["10.1038/nrmicro.2016.17", "PMC5243131", "26972811"]}, {"Citation": "Katsandegwaza B., Horsnell W., Smith K. Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease. Int. J. Mol. Sci. 2022;23:9344. doi: 10.3390/ijms23169344.", "ArticleIdList": ["10.3390/ijms23169344", "PMC9409205", "36012618"]}, {"Citation": "Li Y.-H., Xiao H.-T., Hu D.-D., Fatima S., Lin C.-Y., Mu H.-X., Lee N.P., Bian Z.-X. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses. Pharmacol. Res. 2016;110:227\u2013239. doi: 10.1016/j.phrs.2016.02.010.", "ArticleIdList": ["10.1016/j.phrs.2016.02.010", "26969793"]}, {"Citation": "Osman N., Adawi D., Ahrn\u00e9 S., Jeppsson B., Molin G. Probiotics and Blueberry Attenuate the Severity of Dextran Sulfate Sodium (DSS)-Induced Colitis. Dig. Dis. Sci. 2008;53:2464\u20132473. doi: 10.1007/s10620-007-0174-x.", "ArticleIdList": ["10.1007/s10620-007-0174-x", "18274903"]}, {"Citation": "Young Y., Abreu M.T. Advances in the pathogenesis of inflammatory bowel disease. Curr. Gastroenterol. Rep. 2006;8:470\u2013477. doi: 10.1007/s11894-006-0037-1.", "ArticleIdList": ["10.1007/s11894-006-0037-1", "17105686"]}, {"Citation": "Per\u0161e M., Cerar A. Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks. J. Biomed. Biotechnol. 2012;2012:718617. doi: 10.1155/2012/718617.", "ArticleIdList": ["10.1155/2012/718617", "PMC3361365", "22665990"]}, {"Citation": "D\u00f6nder Y., Arikan T.B., Baykan M., Aky\u00fcz M., \u00d6z A.B. Effects of quercitrin on bacterial translocation in a rat model of experimental colitis. Asian J. Surg. 2018;41:543\u2013550. doi: 10.1016/j.asjsur.2017.12.002.", "ArticleIdList": ["10.1016/j.asjsur.2017.12.002", "29371051"]}, {"Citation": "Romero M., Vera B., Galisteo M., Toral M., G\u00e1lvez J., Perez-Vizcaino F., Duarte J. Protective vascular effects of quercitrin in acute TNBS-colitis in rats: The role of nitric oxide. Food Funct. 2017;8:2702\u20132711. doi: 10.1039/C7FO00755H.", "ArticleIdList": ["10.1039/C7FO00755H", "28703832"]}, {"Citation": "Feng J., Guo C., Zhu Y., Pang L., Yang Z., Zou Y., Zheng X. Baicalin down regulates the expression of TLR4 and NFkB-p65 in colon tissue in mice with colitis induced by dextran sulfate sodium. Int. J. Clin. Exp. Med. 2014;7:4063\u20134072.", "ArticleIdList": ["PMC4276173", "25550915"]}, {"Citation": "Zhu L., Shen H., Gu P., Liu Y., Zhang L., Cheng J. Baicalin alleviates TNBS-induced colitis by inhibiting PI3K/AKT pathway activation. Exp. Ther. Med. 2020;20:581\u2013590. doi: 10.3892/etm.2020.8718.", "ArticleIdList": ["10.3892/etm.2020.8718", "PMC7281943", "32537016"]}, {"Citation": "Wang L.-S., Wang J.-Y., Yao J., Cao X., Zhang R., Li Y.-X., Xu Z.-L., Zhang D.-G. Protective effect of baicalin against experimental colitis via suppression of oxidant stress and apoptosis. Pharmacogn. Mag. 2016;12:225\u2013234. doi: 10.4103/0973-1296.186342.", "ArticleIdList": ["10.4103/0973-1296.186342", "PMC4989799", "27601854"]}, {"Citation": "Li Y., Hu J., Cheng C., Xu F., Au R., Zhu L., Shen H. Baicalin Ameliorates DSS-Induced Colitis by Protecting Goblet Cells through Activating NLRP6 Inflammasomes. Evid. Based Complement. Altern. Med. 2022;2022:2818136. doi: 10.1155/2022/2818136.", "ArticleIdList": ["10.1155/2022/2818136", "PMC9398714", "36016685"]}, {"Citation": "Zou Y., Dai S.X., Chi H.G., Li T., He Z.W., Wang J., Ye C.G., Huang G.L., Zhao B., Li W.Y., et al. Baicalin attenuates TNBS-induced colitis in rats by modulating the Th17/Treg paradigm. Arch. Pharmacal Res. 2015;38:1873\u20131887. doi: 10.1007/s12272-014-0486-2.", "ArticleIdList": ["10.1007/s12272-014-0486-2", "25269538"]}, {"Citation": "Yang L., Shen L., Li Y., Li Y., Yu S., Wang S. Hyperoside attenuates dextran sulfate sodium-induced colitis in mice possibly via activation of the Nrf2 signalling pathway. J. Inflamm. 2017;14:25. doi: 10.1186/s12950-017-0172-5.", "ArticleIdList": ["10.1186/s12950-017-0172-5", "PMC5686943", "29162986"]}, {"Citation": "Cheng C., Zhang W., Zhang C., Ji P., Wu X., Sha Z., Chen X., Wang Y., Chen Y., Cheng H., et al. Hyperoside Ameliorates DSS-Induced Colitis through MKRN1-Mediated Regulation of PPAR\u03b3 Signaling and Th17/Treg Balance. J. Agric. Food Chem. 2021;69:15240\u201315251. doi: 10.1021/acs.jafc.1c06292.", "ArticleIdList": ["10.1021/acs.jafc.1c06292", "34878764"]}, {"Citation": "Szandruk M., Merwid-L\u0105d A., Szel\u0105g A. The impact of mangiferin from Belamcanda chinensis on experimental colitis in rats. Inflammopharmacology. 2018;26:571\u2013581. doi: 10.1007/s10787-017-0337-0.", "ArticleIdList": ["10.1007/s10787-017-0337-0", "PMC5859701", "28337639"]}, {"Citation": "Lim S.M., Jeong J.J., Choi H.S., Chang H.B., Kim D.H. Mangiferin corrects the imbalance of Th17/Treg cells in mice with TNBS-induced colitis. Int. Immunopharmacol. 2016;34:220\u2013228. doi: 10.1016/j.intimp.2016.03.004.", "ArticleIdList": ["10.1016/j.intimp.2016.03.004", "26971225"]}, {"Citation": "Dou W., Zhang J., Ren G., Ding L., Sun A., Deng C., Wu X., Wei X., Mani S., Wang Z. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-\u03baB and MAPK signaling inactivation. Int. Immunopharmacol. 2014;23:170\u2013178. doi: 10.1016/j.intimp.2014.08.025.", "ArticleIdList": ["10.1016/j.intimp.2014.08.025", "PMC4570622", "25194678"]}, {"Citation": "Jin C., Liu J., Jin R., Yao Y., He S., Lei M., Peng X. Linarin ameliorates dextran sulfate sodium-induced colitis in C57BL/6J mice via the improvement of intestinal barrier, suppression of inflammatory responses and modulation of gut microbiota. Food Funct. 2022;13:10574\u201310586. doi: 10.1039/D2FO02128E.", "ArticleIdList": ["10.1039/D2FO02128E", "36155608"]}, {"Citation": "Zhang J., Liang F., Chen Z., Chen Y., Yuan J., Xiong Q., Hou S., Huang S., Liu C., Liang J. Vitexin Protects against Dextran Sodium Sulfate-Induced Colitis in Mice and Its Potential Mechanisms. J. Agric. Food Chem. 2022;70:12041\u201312054. doi: 10.1021/acs.jafc.2c05177.", "ArticleIdList": ["10.1021/acs.jafc.2c05177", "36124900"]}, {"Citation": "Duan S., Du X., Chen S., Liang J., Huang S., Hou S., Gao J., Ding P. Effect of vitexin on alleviating liver inflammation in a dextran sulfate sodium (DSS)-induced colitis model. Biomed. Pharmacother. 2020;121:109683. doi: 10.1016/j.biopha.2019.109683.", "ArticleIdList": ["10.1016/j.biopha.2019.109683", "31810123"]}, {"Citation": "Cao H., Liu J., Shen P., Cai J., Han Y., Zhu K., Fu Y., Zhang N., Zhang Z., Cao Y. Protective Effect of Naringin on DSS-Induced Ulcerative Colitis in Mice. J. Agric. Food Chem. 2018;66:13133\u201313140. doi: 10.1021/acs.jafc.8b03942.", "ArticleIdList": ["10.1021/acs.jafc.8b03942", "30472831"]}, {"Citation": "Hambardikar V.R., Mandlik D.S. Protective effect of naringin ameliorates TNBS-induced colitis in rats via improving antioxidant status and pro-inflammatory cytokines. Immunopharmacol. Immunotoxicol. 2022;44:373\u2013386. doi: 10.1080/08923973.2022.2049813.", "ArticleIdList": ["10.1080/08923973.2022.2049813", "35254187"]}, {"Citation": "Shah T.A., Parikh M., Patel K.V., Patel K.G., Joshi C.G., Gandhi T.R. Evaluation of the effect of Punica granatum juice and punicalagin on NF\u03baB modulation in inflammatory bowel disease. Mol. Cell. Biochem. 2016;419:65\u201374. doi: 10.1007/s11010-016-2750-x.", "ArticleIdList": ["10.1007/s11010-016-2750-x", "27352379"]}, {"Citation": "Wang S., Liu W., Wang J., Bai X. Curculigoside inhibits ferroptosis in ulcerative colitis through the induction of GPX4. Life Sci. 2020;259:118356. doi: 10.1016/j.lfs.2020.118356.", "ArticleIdList": ["10.1016/j.lfs.2020.118356", "32861798"]}, {"Citation": "Li H., Shen L., Lv T., Wang R., Zhang N., Peng H., Diao W. Salidroside attenuates dextran sulfate sodium-induced colitis in mice via SIRT1/FoxOs signaling pathway. Eur. J. Pharmacol. 2019;861:172591. doi: 10.1016/j.ejphar.2019.172591.", "ArticleIdList": ["10.1016/j.ejphar.2019.172591", "31401159"]}, {"Citation": "Liu X., Zhou M., Dai Z., Luo S., Shi Y., He Z., Chen Y. Salidroside alleviates ulcerative colitis via inhibiting macrophage pyroptosis and repairing the dysbacteriosis-associated Th17/Treg imbalance. Phytother. Res. 2023;37:367\u2013382. doi: 10.1002/ptr.7636.", "ArticleIdList": ["10.1002/ptr.7636", "36331009"]}, {"Citation": "Ebrahim H.A., Elsherbini D.M.A. Renovation of Intestinal Barrier by Polydatin in Experimentally Induced Ulcerative Colitis: Comparative Ultrastructural Study with L-Carnosine. Cells Tissues Organs. 2021;210:275\u2013292. doi: 10.1159/000516191.", "ArticleIdList": ["10.1159/000516191", "34461611"]}, {"Citation": "Liu Y.J., Xu W.H., Fan L.M., Zhang Y.Q., Xu W., Chen Y.P., Chen L.L., Chen L., Xu W., Wang Y., et al. Polydatin alleviates DSS- and TNBS-induced colitis by suppressing Th17 cell differentiation via directly inhibiting STAT3. Phytother. Res. 2022;36:3662\u20133671. doi: 10.1002/ptr.7533.", "ArticleIdList": ["10.1002/ptr.7533", "35766233"]}, {"Citation": "Zhang J., Dou W., Zhang E., Sun A., Ding L., Wei X., Chou G., Mani S., Wang Z. Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway. Am. J. Physiol. Liver Physiol. 2014;306:G27\u2013G36. doi: 10.1152/ajpgi.00465.2012.", "ArticleIdList": ["10.1152/ajpgi.00465.2012", "PMC3920084", "24232001"]}, {"Citation": "Gu P., Zhu L., Liu Y., Zhang L., Liu J., Shen H. Protective effects of paeoniflorin on TNBS-induced ulcerative colitis through in-hibiting NF-kappaB pathway and apoptosis in mice. Int. Immunopharmacol. 2017;50:152\u2013160. doi: 10.1016/j.intimp.2017.06.022.", "ArticleIdList": ["10.1016/j.intimp.2017.06.022", "28666238"]}, {"Citation": "Li J., Ren S., Li M., Bi J., Yang G., Li E. Paeoniflorin protects against dextran sulfate sodium (DSS)-induced colitis in mice through inhibition of inflammation and eosinophil infiltration. Int. Immunopharmacol. 2021;97:107667. doi: 10.1016/j.intimp.2021.107667.", "ArticleIdList": ["10.1016/j.intimp.2021.107667", "33887576"]}, {"Citation": "Chen Y.E., Xu S.J., Lu Y.Y., Chen S.X., Du X.H., Hou S.Z., Huang H.Y., Liang J. Asperuloside suppressing oxidative stress and in-flammation in DSS-induced chronic colitis and RAW 264.7 macrophages via Nrf2/HO-1 and NF-\u03baB pathways. Chem. Biol. Interact. 2021;344:109512. doi: 10.1016/j.cbi.2021.109512.", "ArticleIdList": ["10.1016/j.cbi.2021.109512", "33974900"]}, {"Citation": "Liu K., Li G., Guo W., Zhang J. The protective effect and mechanism of pedunculoside on DSS (dextran sulfate sodium) induced ulcerative colitis in mice. Int. Immunopharmacol. 2020;88:107017. doi: 10.1016/j.intimp.2020.107017.", "ArticleIdList": ["10.1016/j.intimp.2020.107017", "33182072"]}, {"Citation": "Yuan H., Ji W.-S., Wu K.-X., Jiao J.-X., Sun L.-H., Feng Y.-T. Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis. World J. Gastroenterol. 2006;12:4578\u20134581. doi: 10.3748/wjg.v12.i28.4578.", "ArticleIdList": ["10.3748/wjg.v12.i28.4578", "PMC4125652", "16874877"]}, {"Citation": "Sethuraman S.N., Swaminathan S., Nelson S.B., Palaninathan P.S., Gopalan T.K., Velayudham P. Modulation of PPAR\u03b3 and TNF\u03b1 by emu oil and glycyrrhizin in ulcerative colitis. Inflammopharmacology. 2015;23:47\u201356. doi: 10.1007/s10787-014-0226-8.", "ArticleIdList": ["10.1007/s10787-014-0226-8", "25560991"]}, {"Citation": "Chen X., Fang D., Li L., Chen L., Li Q., Gong F., Fang M. Glycyrrhizin ameliorates experimental colitis through attenuating inter-leukin-17-producing T cell responses via regulating antigen-presenting cells. Immunol. Res. 2017;65:666\u2013680. doi: 10.1007/s12026-017-8894-2.", "ArticleIdList": ["10.1007/s12026-017-8894-2", "28108937"]}, {"Citation": "Zhong Y., Liu W., Xiong Y., Li Y., Wan Q., Zhou W., Zhao H., Xiao Q., Liu D. Astragaloside \u2163 alleviates ulcerative colitis by regu-lating the balance of Th17/Treg cells. Phytomedicine. 2022;104:154287. doi: 10.1016/j.phymed.2022.154287.", "ArticleIdList": ["10.1016/j.phymed.2022.154287", "35752072"]}, {"Citation": "Niu Y.-T., Zhao Y.-P., Jiao Y.-F., Zheng J., Yang W.-L., Zhou R., Niu Y., Sun T., Li Y.-X., Yu J.-Q. Protective effect of gentiopicroside against dextran sodium sulfate induced colitis in mice. Int. Immunopharmacol. 2016;39:16\u201322. doi: 10.1016/j.intimp.2016.07.003.", "ArticleIdList": ["10.1016/j.intimp.2016.07.003", "27394986"]}, {"Citation": "Cheng H., Liu J., Zhang D., Wang J., Tan Y., Feng W., Peng C. Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism. Front. Immunol. 2022;13:817600. doi: 10.3389/fimmu.2022.817600.", "ArticleIdList": ["10.3389/fimmu.2022.817600", "PMC9152015", "35655785"]}, {"Citation": "Zhang Z., Yang L., Wang B., Zhang L., Zhang Q., Li D., Zhang S., Gao H., Wang X. Protective role of liriodendrin in mice with dextran sulphate sodium-induced ulcerative colitis. Int. Immunopharmacol. 2017;52:203\u2013210. doi: 10.1016/j.intimp.2017.09.012.", "ArticleIdList": ["10.1016/j.intimp.2017.09.012", "28941417"]}, {"Citation": "Li M.Y., Zhang Z.H., Wang Z., Zuo H.X., Wang J.Y., Xing Y., Jin C.H., Xu G.H., Piao L.X., Ma J., et al. Convallatoxin protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-\u03baB signaling through activation of PPAR\u03b3. Pharmacol. Res. 2019;147:104355. doi: 10.1016/j.phrs.2019.104355.", "ArticleIdList": ["10.1016/j.phrs.2019.104355", "31386886"]}, {"Citation": "Jiang H., Shi G.-F., Fang Y.-X., Liu Y.-Q., Wang Q., Zheng X., Zhang D.-J., Zhang J., Yin Z.-Q. Aloin A prevents ulcerative colitis in mice by enhancing the intestinal barrier function via suppressing the Notch signaling pathway. Phytomedicine. 2022;106:154403. doi: 10.1016/j.phymed.2022.154403.", "ArticleIdList": ["10.1016/j.phymed.2022.154403", "36075180"]}, {"Citation": "Stavric B. Role of chemopreventers in human diet. Clin. Biochem. 1994;27:319\u2013332. doi: 10.1016/0009-9120(94)00039-5.", "ArticleIdList": ["10.1016/0009-9120(94)00039-5", "7867212"]}, {"Citation": "Formica J., Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 1995;33:1061\u20131080. doi: 10.1016/0278-6915(95)00077-1.", "ArticleIdList": ["10.1016/0278-6915(95)00077-1", "8847003"]}, {"Citation": "Bors W., Heller W., Michel C., Saran M. [36] Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. Methods Enzymol. 1990;186:343\u2013355. doi: 10.1016/0076-6879(90)86128-i.", "ArticleIdList": ["10.1016/0076-6879(90)86128-i", "2172711"]}, {"Citation": "Skaper S.D., Fabris M., Ferrari V., Carbonare M.D., Leon A. Quercetin Protects Cutaneous Tissue-Associated Cell Types Including Sensory Neurons From Oxidative Stress Induced By Glutathione Depletion: Cooperative Effects of Ascorbic Acid. Free. Radic. Biol. Med. 1997;22:669\u2013678. doi: 10.1016/S0891-5849(96)00383-8.", "ArticleIdList": ["10.1016/S0891-5849(96)00383-8", "9013129"]}, {"Citation": "Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart dis-ease: The Zutphen Elderly Study. Lancet. 1993;342:1007\u20131711. doi: 10.1016/0140-6736(93)92876-U.", "ArticleIdList": ["10.1016/0140-6736(93)92876-U", "8105262"]}, {"Citation": "Cao G., Sofic E., Prior R.L. Antioxidant and Prooxidant Behavior of Flavonoids: Structure-Activity Relationships. Free Radic. Biol. Med. 1997;22:749\u2013760. doi: 10.1016/S0891-5849(96)00351-6.", "ArticleIdList": ["10.1016/S0891-5849(96)00351-6", "9119242"]}, {"Citation": "Gryglewski R.J., Korbut R., Robak J., \u015awi\u0229s J. On the mechanism of antithrombotic action of flavonoids. Biochem. Pharmacol. 1987;36:317\u2013322. doi: 10.1016/0006-2952(87)90288-7.", "ArticleIdList": ["10.1016/0006-2952(87)90288-7", "3101704"]}, {"Citation": "Dou W., Mukherjee S., Li H., Venkatesh M., Wang H., Kortagere S., Peleg A., Chilimuri S.S., Wang Z.T., Feng Y., et al. Alleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitis. PLoS ONE. 2012;7:e36075. doi: 10.1371/journal.pone.0036075.", "ArticleIdList": ["10.1371/journal.pone.0036075", "PMC3398007", "22815676"]}, {"Citation": "Hong T., Jin G.-B., Cho S., Cyong J.-C. Evaluation of the Anti-Inflammatory Effect of Baicalein on Dextran Sulfate Sodium-Induced Colitis in Mice. Planta Medica. 2002;68:268\u2013271. doi: 10.1055/s-2002-23143.", "ArticleIdList": ["10.1055/s-2002-23143", "11914968"]}, {"Citation": "Brackman G., Cos P., Maes L., Nelis H.J., Coenye T. Quorum Sensing Inhibitors Increase the Susceptibility of Bacterial Biofilms to Antibiotics In Vitro and In Vivo. Antimicrob. Agents Chemother. 2011;55:2655\u20132661. doi: 10.1128/AAC.00045-11.", "ArticleIdList": ["10.1128/AAC.00045-11", "PMC3101409", "21422204"]}, {"Citation": "Yuan Y., Shuai L., Chen S., Huang L., Qin S., Yang Z. Flavonoids and antioxidative enzymes in temperature-challenged roots of Scutellaria baicalensis Georgi. Z. F\u00fcr Nat. C J. Biosci. 2012;67:77\u201385.", "ArticleIdList": ["22486044"]}, {"Citation": "Chen D., Wu Y.-X., Qiu Y.-B., Wan B.-B., Liu G., Chen J.-L., Lu M.-D., Pang Q.-F. Hyperoside suppresses hypoxia-induced A549 survival and proliferation through ferrous accumulation via AMPK/HO-1 axis. Phytomedicine. 2020;67:153138. doi: 10.1016/j.phymed.2019.153138.", "ArticleIdList": ["10.1016/j.phymed.2019.153138", "31881478"]}, {"Citation": "Sun Y., Sun F., Feng W., Qiu X., Liu Y., Yang B., Chen Y., Xia P. Hyperoside inhibits biofilm formation of Pseudomonas aeruginosa. Exp. Ther. Med. 2017;14:1647\u20131652. doi: 10.3892/etm.2017.4641.", "ArticleIdList": ["10.3892/etm.2017.4641", "PMC5526060", "28810631"]}, {"Citation": "Matkowski A., Ku\u015b P., G\u00f3ralska E., Wo\u017aniak D. Mangiferin\u2014A bioactive xanthonoid, not only from mango and not just antiox-idant. Mini Rev. Med. Chem. 2013;13:439\u2013455.", "ArticleIdList": ["23190031"]}, {"Citation": "Jung K., Lee B., Han S.J., Ryu J.H., Kim D.-H. Mangiferin Ameliorates Scopolamine-Induced Learning Deficits in Mice. Biol. Pharm. Bull. 2009;32:242\u2013246. doi: 10.1248/bpb.32.242.", "ArticleIdList": ["10.1248/bpb.32.242", "19182383"]}, {"Citation": "McKay D.L., Blumberg J.B. A review of the bioactivity of south African herbal teas: Rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia) Phytother. Res. 2007;21:1\u201316. doi: 10.1002/ptr.1992.", "ArticleIdList": ["10.1002/ptr.1992", "16927447"]}, {"Citation": "M\u00e1rquez L., Garc\u00eda-Bueno B., Madrigal J.L.M., Leza J.C. Mangiferin decreases inflammation and oxidative damage in rat brain after stress. Eur. J. Nutr. 2012;51:729\u2013739. doi: 10.1007/s00394-011-0252-x.", "ArticleIdList": ["10.1007/s00394-011-0252-x", "21986672"]}, {"Citation": "Mottaghipisheh J., Taghrir H., Dehsheikh A.B., Zomorodian K., Irajie C., Sourestani M.M., Iraji A. Linarin, a Glycosylated Flavonoid, with Potential Therapeutic Attributes: A Comprehensive Review. Pharmaceuticals. 2021;14:1104. doi: 10.3390/ph14111104.", "ArticleIdList": ["10.3390/ph14111104", "PMC8621830", "34832886"]}, {"Citation": "Chengyu Y., Long Z., Bin Z., Hong L., Xuefei S., Congjuan L., Caixia C., Yan X. Linarin Protects the Kidney against Ische-mia/Reperfusion Injury via the Inhibition of Bioactive ETS2/IL-12. Biol. Pharm. Bull. 2021;44:25\u201331. doi: 10.1248/bpb.b20-00508.", "ArticleIdList": ["10.1248/bpb.b20-00508", "33390546"]}, {"Citation": "Qi W., Chen Y., Sun S., Xu X., Zhan J., Yan Z., Shang P., Pan X., Liu H. Inhibiting TLR4 signaling by linarin for preventing in-flammatory response in osteoarthritis. Aging. 2021;13:5369\u20135382. doi: 10.18632/aging.202469.", "ArticleIdList": ["10.18632/aging.202469", "PMC7950270", "33536347"]}, {"Citation": "Han X., Wu Y.C., Meng M., Sun Q.S., Gao S.M., Sun H. Linarin prevents LPS induced acute lung injury by suppressing oxidative stress and inflammation via inhibition of TXNIP/NLRP3 and NF \u03baB pathways. Int. J. Mol. Med. 2018;42:1460\u20131472. doi: 10.3892/ijmm.2018.3710.", "ArticleIdList": ["10.3892/ijmm.2018.3710", "PMC6089707", "29845284"]}, {"Citation": "Gadioli I.L., da Cunha M.S.B., de Carvalho M.V.O., Costa A.M., Pineli L.L.O. A systematic review on phenolic compounds in Passiflora plants: Exploring biodiversity for food, nutrition, and popular medicine. Crit. Rev. Food Sci. Nutr. 2018;58:785\u2013807. doi: 10.1080/10408398.2016.1224805.", "ArticleIdList": ["10.1080/10408398.2016.1224805", "27645583"]}, {"Citation": "Rivoira M.A., Rodriguez V., Talamoni G., de Talamoni N.T. New Perspectives in the Pharmacological Potential of Naringin in Medicine. Curr. Med. Chem. 2021;28:1987\u20132007. doi: 10.2174/0929867327666200604171351.", "ArticleIdList": ["10.2174/0929867327666200604171351", "32496985"]}, {"Citation": "Li C., Zhang J., Lv F., Ge X., Li G. Naringin protects against bone loss in steroid-treated inflammatory bowel disease in a rat model. Arch. Biochem. Biophys. 2018;650:22\u201329. doi: 10.1016/j.abb.2018.05.011.", "ArticleIdList": ["10.1016/j.abb.2018.05.011", "29753722"]}, {"Citation": "Cao Y., Chen J., Ren G., Zhang Y., Tan X., Yang L. Punicalagin Prevents Inflammation in LPS- Induced RAW264.7 Macrophages by Inhibiting FoxO3a/Autophagy Signaling Pathway. Nutrients. 2019;11:2794. doi: 10.3390/nu11112794.", "ArticleIdList": ["10.3390/nu11112794", "PMC6893462", "31731808"]}, {"Citation": "Xu X., Li H., Hou X., Li D., He S., Wan C., Yin P., Liu M., Liu F., Xu J. Punicalagin Induces Nrf2/HO-1 Expression via Upregulation of PI3K/AKT Pathway and Inhibits LPS-Induced Oxidative Stress in RAW264.7 Macrophages. Mediat. Inflamm. 2015;2015:380218. doi: 10.1155/2015/380218.", "ArticleIdList": ["10.1155/2015/380218", "PMC4417599", "25969626"]}, {"Citation": "Adams L.S., Seeram N.P., Aggarwal B.B., Takada Y., Sand D., Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agric. Food Chem. 2006;54:980\u2013985. doi: 10.1021/jf052005r.", "ArticleIdList": ["10.1021/jf052005r", "16448212"]}, {"Citation": "Aqil F., Munagala R., Vadhanam M.V., Kausar H., Jeyabalan J., Schultz D.J., Gupta R.C. Anti-proliferative activity and protection against oxidative DNA damage by punicalagin isolated from pomegranate husk. Food Res. Int. 2012;49:345\u2013353. doi: 10.1016/j.foodres.2012.07.059.", "ArticleIdList": ["10.1016/j.foodres.2012.07.059", "PMC3593254", "23493479"]}, {"Citation": "Zhao Y., Guo Y., Chen Y., Liu S., Wu N., Jia D. Curculigoside attenuates myocardial ischemia-reperfusion injury by inhibiting the opening of the mitochondrial permeability transition pore. Int. J. Mol. Med. 2020;45:1514\u20131524. doi: 10.3892/ijmm.2020.4513.", "ArticleIdList": ["10.3892/ijmm.2020.4513", "PMC7138276", "32323742"]}, {"Citation": "Tan S., Xu J., Lai A., Cui R., Bai R., Li S., Liang W., Zhang G., Jiang S., Liu S., et al. Curculigoside exerts significant anti arthritic effects in vivo and in vitro via regulation of the JAK/STAT/NF \u03baB signaling pathway. Mol. Med. Rep. 2019;19:2057\u20132064. doi: 10.3892/mmr.2019.9854.", "ArticleIdList": ["10.3892/mmr.2019.9854", "PMC6390071", "30664158"]}, {"Citation": "Wu Q., Fu D.X., Hou A.J., Lei G.Q., Liu Z.J., Chen J.K., Zhou T.S. Antioxidative phenols and phenolic glycosides from Curculigo or-chioides. Chem. Pharm. Bull. 2005;53:1065\u20131067. doi: 10.1248/cpb.53.1065.", "ArticleIdList": ["10.1248/cpb.53.1065", "16079552"]}, {"Citation": "Wang L., He Y.-J., Han T., Zhao L., Lv L., He Y.-Q., Zhang Q.-Y., Xin H.-L. Metabolites of curculigoside in rats and their antiosteoporotic activities in osteoblastic MC3T3-E1 cells. Fitoterapia. 2017;117:109\u2013117. doi: 10.1016/j.fitote.2017.01.009.", "ArticleIdList": ["10.1016/j.fitote.2017.01.009", "28126417"]}, {"Citation": "Chen X., Zhang Q., Cheng Q., Ding F. Protective effect of salidroside against H2O2-induced cell apoptosis in primary culture of rat hippocampal neurons. Mol. Cell. Biochem. 2009;332:85\u201393. doi: 10.1007/s11010-009-0177-3.", "ArticleIdList": ["10.1007/s11010-009-0177-3", "19554425"]}, {"Citation": "Zhu Y., Shi Y.P., Wu D., Ji Y.J., Wang X., Chen H.L., Wu S.S., Huang D.J., Jiang W. Salidroside protects against hydrogen perox-ide-induced injury in cardiac H9c2 cells via PI3K-Akt dependent pathway. DNA Cell Biol. 2011;30:809\u2013819. doi: 10.1089/dna.2010.1183.", "ArticleIdList": ["10.1089/dna.2010.1183", "21563965"]}, {"Citation": "Gao J., Zhou R., You X., Luo F., He H., Chang X., Zhu L., Ding X., Yan T. Salidroside suppresses inflammation in a D-galactose-induced rat model of Alzheimer\u2019s disease via SIRT1/NF-\u03baB pathway. Metab. Brain Dis. 2016;31:771\u2013778. doi: 10.1007/s11011-016-9813-2.", "ArticleIdList": ["10.1007/s11011-016-9813-2", "26909502"]}, {"Citation": "Ahmad P., Alvi S.S., Iqbal D., Khan M.S. Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis. Life Sci. 2020;254:117756. doi: 10.1016/j.lfs.2020.117756.", "ArticleIdList": ["10.1016/j.lfs.2020.117756", "32389832"]}, {"Citation": "Chen P., Wang L., Sun S., Zhou Q., Zeng Z., Zehua Z., Hussain M., Lu C., Du H. High-throughput screening suggests glutathione synthetase as an anti-tumor target of polydatin using human proteome chip. Int. J. Biol. Macromol. 2020;161:1230\u20131239. doi: 10.1016/j.ijbiomac.2020.06.061.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.06.061", "32544581"]}, {"Citation": "Sun Z., Wang X. Protective effects of polydatin on multiple organ ischemia-reperfusion injury. Bioorg. Chem. 2020;94:103485. doi: 10.1016/j.bioorg.2019.103485.", "ArticleIdList": ["10.1016/j.bioorg.2019.103485", "31836186"]}, {"Citation": "Gao Y., Dai X., Li Y., Li G., Lin X., Ai C., Cao Y., Li T., Lin B. Role of Parkin-mediated mitophagy in the protective effect of polydatin in sepsis-induced acute kidney injury. J. Transl. Med. 2020;18:114. doi: 10.1186/s12967-020-02283-2.", "ArticleIdList": ["10.1186/s12967-020-02283-2", "PMC7055075", "32131850"]}, {"Citation": "Chen X., Chan H., Zhang L., Liu X., Ho I.H.T., Zhang X., Ho J., Hu W., Tian Y., Kou S., et al. The phytochemical polydatin ameliorates non-alcoholic steatohepatitis by restoring lysosomal function and au-tophagic flux. J. Cell. Mol. Med. 2019;23:4290\u20134300. doi: 10.1111/jcmm.14320.", "ArticleIdList": ["10.1111/jcmm.14320", "PMC6533566", "30973211"]}, {"Citation": "Huang Q.H., Xu L.Q., Liu Y.H., Wu J.Z., Wu X., Lai X.P., Li Y.C., Su Z.R., Chen J.N., Xie Y.L. Polydatin Protects Rat Liver against Etha-nol-Induced Injury: Involvement of CYP2E1/ROS/Nrf2 and TLR4/NF-\u03baB p65 Pathway. Evid. Based Complement. Altern. Med. 2017;2017:7953850. doi: 10.1155/2017/7953850.", "ArticleIdList": ["10.1155/2017/7953850", "PMC5698823", "29250126"]}, {"Citation": "Huang B., Liu J., Meng T., Li Y., He D., Ran X., Chen G., Guo W., Kan X., Fu S., et al. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson\u2019s Disease via Regulation of the AKT/GSK3\u03b2-Nrf2/NF-\u03baB Signaling Axis. Front. Immunol. 2018;9:2527. doi: 10.3389/fimmu.2018.02527.", "ArticleIdList": ["10.3389/fimmu.2018.02527", "PMC6230593", "30455692"]}, {"Citation": "Peng Y., Xu J., Zeng Y., Chen L., Le Xu X. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport. Phytomedicine. 2019;62:152935. doi: 10.1016/j.phymed.2019.152935.", "ArticleIdList": ["10.1016/j.phymed.2019.152935", "31085374"]}, {"Citation": "Bheereddy P., Yerra V.G., Kalvala A.K., Sherkhane B., Kumar A. SIRT1 Activation by Polydatin Alleviates Oxidative Damage and Elevates Mitochondrial Biogenesis in Experimental Diabetic Neuropathy. Cell. Mol. Neurobiol. 2021;41:1563\u20131577. doi: 10.1007/s10571-020-00923-1.", "ArticleIdList": ["10.1007/s10571-020-00923-1", "32683581"]}, {"Citation": "Xiao H.-B., Liang L., Luo Z.-F., Sun Z.-L. Paeoniflorin regulates GALNT2-ANGPTL3-LPL pathway to attenuate dyslipidemia in mice. Eur. J. Pharmacol. 2018;836:122\u2013128. doi: 10.1016/j.ejphar.2018.08.006.", "ArticleIdList": ["10.1016/j.ejphar.2018.08.006", "30096295"]}, {"Citation": "Lal R., Dhaliwal J., Dhaliwal N., Dharavath R.N., Chopra K. Activation of the Nrf2/HO-1 signaling pathway by dimethyl fumarate ameliorates complete Freund\u2019s adjuvant-induced arthritis in rats. Eur. J. Pharmacol. 2021;899:174044. doi: 10.1016/j.ejphar.2021.174044.", "ArticleIdList": ["10.1016/j.ejphar.2021.174044", "33745959"]}, {"Citation": "Liu C., Zhang W., Yang H., Sun W., Gong X., Zhao J., Sun Y., Diao G. A Water-Soluble Inclusion Complex of Pedunculoside with the Polymer \u03b2-Cyclodextrin: A Novel Anti-Inflammation Agent with Low Toxicity. PLoS ONE. 2014;9:e101761. doi: 10.1371/journal.pone.0101761.", "ArticleIdList": ["10.1371/journal.pone.0101761", "PMC4094462", "25013908"]}, {"Citation": "Liu C., Shen Y.-J., Tu Q.-B., Zhao Y.-R., Guo H., Wang J., Zhang L., Shi H.-W., Sun Y. Pedunculoside, a novel triterpene saponin extracted from Ilex rotunda, ameliorates high-fat diet induced hyperlipidemia in rats. Biomed. Pharmacother. 2018;101:608\u2013616. doi: 10.1016/j.biopha.2018.02.131.", "ArticleIdList": ["10.1016/j.biopha.2018.02.131", "29518607"]}, {"Citation": "Ma X., Chen G., Wang J., Xu J., Zhao F., Hu M., Xu Z., Yang B., Guo J., Sun S., et al. Pedunculoside attenuates pathological phe-notypes of fibroblast-like synoviocytes and protects against collagen-induced arthritis. Scand. J. Rheumatol. 2019;48:383\u2013392. doi: 10.1080/03009742.2019.1600716.", "ArticleIdList": ["10.1080/03009742.2019.1600716", "31354003"]}, {"Citation": "Gao L., Tang H., He H., Liu J., Mao J., Ji H., Lin H., Wu T. Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats. Front. Pharmacol. 2015;6:215. doi: 10.3389/fphar.2015.00215.", "ArticleIdList": ["10.3389/fphar.2015.00215", "PMC4589765", "26483688"]}, {"Citation": "Deng Q.-P., Wang M.-J., Zeng X., Chen G.G., Huang R.-Y. Effects of Glycyrrhizin in a Mouse Model of Lung Adenocarcinoma. Cell. Physiol. Biochem. 2017;41:1383\u20131392. doi: 10.1159/000467897.", "ArticleIdList": ["10.1159/000467897", "28315871"]}, {"Citation": "Yang Q., Wang J., Liu R., Wang Z., Li Y., Zhang Y., Hao X., Huang Y., Xie W., Wei H. Amelioration of concanavalin A-induced au-toimmune hepatitis by magnesium isoglycyrrhizinate through inhibition of CD4(+)CD25(-)CD69(+) subset proliferation. Drug Des. Dev. Ther. 2016;10:443\u2013453.", "ArticleIdList": ["PMC4734720", "26869766"]}, {"Citation": "Sui Y.-B., Zhang K.-K., Ren Y.-K., Liu L., Liu Y. The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure. Pharm. Biol. 2020;58:1201\u20131207. doi: 10.1080/13880209.2020.1849319.", "ArticleIdList": ["10.1080/13880209.2020.1849319", "PMC7717863", "33253607"]}, {"Citation": "Chen J.K., Guo M.K., Bai X.H., Chen L.Q., Su S.M., Li L., Li J.Q. Astragaloside IV ameliorates intermittent hypoxia-induced inflam-matory dysfunction by suppressing MAPK/NF-\u03baB signalling pathways in Beas-2B cells. Sleep Breath. 2020;24:1237\u20131245. doi: 10.1007/s11325-019-01947-8.", "ArticleIdList": ["10.1007/s11325-019-01947-8", "31907823"]}, {"Citation": "Wang Y., Jiang F., Cheng H., Tan X., Liu Y., Wei C., Song E. Astragaloside IV Protects Against Oxidative Stress in Calf Small Intestine Epithelial Cells via NFE2L2-Antioxidant Response Element Signaling. Int. J. Mol. Sci. 2019;20:6131. doi: 10.3390/ijms20246131.", "ArticleIdList": ["10.3390/ijms20246131", "PMC6941087", "31817362"]}, {"Citation": "Hase K., Li J., Basnet P., Xiong Q., Takamura S., Namba T., Kadota S. Hepatoprotective Principles of Swertia japonica Makino on D-Galactosamine/Lipopolysaccharide-Induced Liver Injury in Mice. Chem. Pharm. Bull. 1997;45:1823\u20131827. doi: 10.1248/cpb.45.1823.", "ArticleIdList": ["10.1248/cpb.45.1823", "9396160"]}, {"Citation": "Ozt\u00fcrk N., Korkmaz S., Ozt\u00fcrk Y., Ba\u015fer K.H. Effects of gentiopicroside, sweroside and swertiamarine, secoiridoids from gentian (Gentiana lutea ssp. symphyandra), on cultured chicken embryonic fibroblasts. Planta Med. 2006;72:289\u2013294. doi: 10.1055/s-2005-916198.", "ArticleIdList": ["10.1055/s-2005-916198", "16557467"]}, {"Citation": "Zhao A., Liu N., Yao M., Zhang Y., Yao Z., Feng Y., Liu J., Zhou G. A Review of Neuroprotective Effects and Mechanisms of Gin-senosides From Panax Ginseng in Treating Ischemic Stroke. Front. Pharmacol. 2022;13:946752. doi: 10.3389/fphar.2022.946752.", "ArticleIdList": ["10.3389/fphar.2022.946752", "PMC9302711", "35873557"]}, {"Citation": "Zhang L., Zhu M., Li M., Du Y., Duan S., Huang Y., Lu Y., Zhang J., Wang T., Fu F. Ginsenoside Rg1 attenuates adjuvant-induced arthritis in rats via modulation of PPAR-\u03b3/NF-\u03baB signal pathway. Oncotarget. 2017;8:55384\u201355393. doi: 10.18632/oncotarget.19526.", "ArticleIdList": ["10.18632/oncotarget.19526", "PMC5589666", "28903427"]}, {"Citation": "Wang T., Gao Y., Yue R., Wang X., Shi Y., Xu J., Wu B., Li Y. Ginsenoside Rg1 Alleviates Podocyte Injury Induced by Hyperlipidemia via Targeting the mTOR/NF-\u03baB/NLRP3 Axis. Evid. Based Complement. Altern. Med. 2020;2020:2735714. doi: 10.1155/2020/2735714.", "ArticleIdList": ["10.1155/2020/2735714", "PMC7568787", "33133213"]}, {"Citation": "Liu H., Wang J., Liu M., Zhao H., Yaqoob S., Zheng M., Cai D., Liu J. Antiobesity Effects of Ginsenoside Rg1 on 3T3-L1 Preadipocytes and High Fat Diet-Induced Obese Mice Mediated by AMPK. Nutrients. 2018;10:830. doi: 10.3390/nu10070830.", "ArticleIdList": ["10.3390/nu10070830", "PMC6073290", "29954059"]}, {"Citation": "Alolga R.N., Nuer-Allornuvor G.F., Kuugbee E.D., Yin X., Ma G. Ginsenoside Rg1 and the control of inflammation implications for the therapy of type 2 diabetes: A review of scientific findings and call for further research. Pharmacol. Res. 2020;152:104630. doi: 10.1016/j.phrs.2020.104630.", "ArticleIdList": ["10.1016/j.phrs.2020.104630", "31911245"]}, {"Citation": "Li D.H., Wang Y., Lv Y.S., Liu J.H., Yang L., Zhang S.K., Zhuo Y.Z. Preparative Purification of Liriodendrin from Sargentodoxa cu-neata by Macroporous Resin. BioMed Res. Int. 2015;2015:861256.", "ArticleIdList": ["PMC4508389", "26236742"]}, {"Citation": "Jin C.M., Lee J.J., Yang Y.J., Kim Y.M., Kim Y.K., Ryu S.Y., Lee M.K. Liriodenine inhibits dopamine biosynthesis and L-DOPA-induced dopamine content in PC12 cells. Arch. Pharmacal Res. 2007;30:984\u2013990. doi: 10.1007/BF02993967.", "ArticleIdList": ["10.1007/BF02993967", "17879752"]}, {"Citation": "Clark A.M., Watson E.S., Ashfaq M.K., Hufford C.D. In vivo efficacy of antifungal oxoaporphine alkaloids in experimental dis-seminated candidiasis. Pharm. Res. 1987;4:495\u2013498. doi: 10.1023/A:1016479622383.", "ArticleIdList": ["10.1023/A:1016479622383", "3508563"]}, {"Citation": "Chen K.-S., Wu Y.-C., Teng C.-M., Ko F.-N., Wu T.-S. Bioactive Alkaloids from Illigera luzonensis. J. Nat. Prod. 1997;60:645\u2013647. doi: 10.1021/np9700735.", "ArticleIdList": ["10.1021/np9700735", "9214740"]}, {"Citation": "Wu Y.C., Yamagishi T., Lee K.H. Cytotoxic isoquinoline alkaloids from Xanthorhiza simplicissima. Gaoxiong Yi Xue Ke Xue Za Zhi. 1989;5:409\u2013411.", "ArticleIdList": ["2810448"]}, {"Citation": "Shang X., Miao X., Yang F., Wang C., Li B., Wang W., Pan H., Guo X., Zhang Y., Zhang J. The Genus Adonis as an Important Cardiac Folk Medicine: A Review of the Ethnobotany, Phytochemistry and Pharmacology. Front. Pharmacol. 2019;10:25. doi: 10.3389/fphar.2019.00025.", "ArticleIdList": ["10.3389/fphar.2019.00025", "PMC6369255", "30778296"]}, {"Citation": "Zhang Z.H., Li M.Y., Wang Z., Zuo H.X., Wang J.Y., Xing Y., Jin C., Xu G., Piao L., Piao H., et al. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer. Phytomedicine. 2020;68:153172. doi: 10.1016/j.phymed.2020.153172.", "ArticleIdList": ["10.1016/j.phymed.2020.153172", "32004989"]}, {"Citation": "Anderson S.E., Barton C.E. The cardiac glycoside convallatoxin inhibits the growth of colorectal cancer cells in a p53-independent manner. Mol. Genet. Metab. Rep. 2017;13:42\u201345. doi: 10.1016/j.ymgmr.2017.07.011.", "ArticleIdList": ["10.1016/j.ymgmr.2017.07.011", "PMC5548364", "28819586"]}, {"Citation": "Lee J., Kang J.S., Nam L.B., Yoo O.K., Keum Y.S. Suppression of NRF2/ARE by convallatoxin sensitises A549 cells to 5-FU-mediated apoptosis. Free Radic. Res. 2018;52:1416\u20131423. doi: 10.1080/10715762.2018.1489132.", "ArticleIdList": ["10.1080/10715762.2018.1489132", "29902094"]}, {"Citation": "Jiang B.-W., Zhang W.-J., Wang Y., Tan L.-P., Bao Y.-L., Song Z.-B., Yu C.-L., Wang S.-Y., Liu L., Li Y.-X. Convallatoxin induces HaCaT cell necroptosis and ameliorates skin lesions in psoriasis-like mouse models. Biomed. Pharmacother. 2020;121:109615. doi: 10.1016/j.biopha.2019.109615.", "ArticleIdList": ["10.1016/j.biopha.2019.109615", "31707343"]}, {"Citation": "S\u00e1nchez M., Gonz\u00e1lez-Burgos E., Iglesias I., G\u00f3mez-Serranillos M.P. Pharmacological Update Properties of Aloe Vera and its Major Active Constituents. Molecules. 2020;25:1324. doi: 10.3390/molecules25061324.", "ArticleIdList": ["10.3390/molecules25061324", "PMC7144722", "32183224"]}, {"Citation": "Carty E., Macey M., Rampton D.S. Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease. Aliment. Pharmacol. Ther. 2000;14:1169\u20131179. doi: 10.1046/j.1365-2036.2000.00824.x.", "ArticleIdList": ["10.1046/j.1365-2036.2000.00824.x", "10971234"]}, {"Citation": "Biasi F., Leonarduzzi G.M., Oteiza P.I., Poli G. Inflammatory Bowel Disease: Mechanisms, Redox Considerations, and Therapeutic Targets. Antioxid. Redox Signal. 2013;19:1711\u20131747. doi: 10.1089/ars.2012.4530.", "ArticleIdList": ["10.1089/ars.2012.4530", "PMC3809610", "23305298"]}, {"Citation": "Siegmund B., Zeitz M. Innate and adaptive immunity in inflammatory bowel disease. World J. Gastroenterol. 2011;17:3178\u20133183.", "ArticleIdList": ["PMC3158392", "21912465"]}, {"Citation": "Xu C.-M., Li X.-M., Qin B.-Z., Liu B. Effect of tight junction protein of intestinal epithelium and permeability of colonic mucosa in pathogenesis of injured colonic barrier during chronic recovery stage of rats with inflammatory bowel disease. Asian Pac. J. Trop. Med. 2016;9:148\u2013152. doi: 10.1016/j.apjtm.2016.01.001.", "ArticleIdList": ["10.1016/j.apjtm.2016.01.001", "26919945"]}, {"Citation": "Van Dieren J.M., Kuipers E.J., Samsom J.N., Nieuwenhuis E.E., Van Der Woude J.C. Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: Their mechanisms of action and role in the treatment of IBD. Inflamm. Bowel Dis. 2006;12:311\u2013327. doi: 10.1097/01.MIB.0000209787.19952.53.", "ArticleIdList": ["10.1097/01.MIB.0000209787.19952.53", "16633053"]}, {"Citation": "Eastaff-Leung N., Mabarrack N., Barbour A., Cummins A., Barry S. Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease. J. Clin. Immunol. 2010;30:80\u201389. doi: 10.1007/s10875-009-9345-1.", "ArticleIdList": ["10.1007/s10875-009-9345-1", "19936899"]}, {"Citation": "Ogino H., Nakamura K., Ihara E., Akiho H., Takayanagi R. CD4+CD25+ regulatory T cells suppress Th17-responses in an ex-perimental colitis model. Dig. Dis. Sci. 2011;56:376\u2013386. doi: 10.1007/s10620-010-1286-2.", "ArticleIdList": ["10.1007/s10620-010-1286-2", "20521112"]}, {"Citation": "Lee Y.K., Mukasa R., Hatton R.D., Weaver C.T. Developmental plasticity of Th17 and Treg cells. Curr. Opin. Immunol. 2009;21:274\u2013280. doi: 10.1016/j.coi.2009.05.021.", "ArticleIdList": ["10.1016/j.coi.2009.05.021", "19524429"]}, {"Citation": "Hollenbach E., Neumann M., Vieth M., Roessner A., Malfertheiner P., Naumann M. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J. 2004;18:1550\u20131552. doi: 10.1096/fj.04-1642fje.", "ArticleIdList": ["10.1096/fj.04-1642fje", "15289440"]}, {"Citation": "Roy P.K., Rashid F., Bragg J., Ibdah J.A. Role of the JNK signal transduction pathway in inflammatory bowel disease. World J. Gastroenterol. 2008;14:200\u2013202. doi: 10.3748/wjg.14.200.", "ArticleIdList": ["10.3748/wjg.14.200", "PMC2675114", "18186555"]}, {"Citation": "Li Y., Zhang L., Wang W., Liu Y., Sun D., Li H., Chen L. A review on natural products with cage-like structure. Bioorganic Chem. 2022;128:106106. doi: 10.1016/j.bioorg.2022.106106.", "ArticleIdList": ["10.1016/j.bioorg.2022.106106", "36037599"]}, {"Citation": "Low Z., Lani R., Tiong V., Poh C., AbuBakar S., Hassandarvish P. COVID-19 Therapeutic Potential of Natural Products. Int. J. Mol. Sci. 2023;24:9589. doi: 10.3390/ijms24119589.", "ArticleIdList": ["10.3390/ijms24119589", "PMC10254072", "37298539"]}, {"Citation": "Ooi S.L., Pak S.C. Editorial: A Feasible Approach for Natural Products to Treatment of Diseases. Molecules. 2023;28:3791. doi: 10.3390/molecules28093791.", "ArticleIdList": ["10.3390/molecules28093791", "PMC10180473", "37175201"]}, {"Citation": "Lu Q., Tan D., Luo J., Ye Y., Zuo M., Wang S., Li C. Potential of natural products in the treatment of irritable bowel syndrome. Phytomedicine. 2022;106:154419. doi: 10.1016/j.phymed.2022.154419.", "ArticleIdList": ["10.1016/j.phymed.2022.154419", "36087525"]}, {"Citation": "Li J.H. The prospect of development and application of natural drugs. Med. Rev. 2002;8:472\u2013475."}, {"Citation": "Coussens L.M., Werb Z. Inflammation and cancer. Nature. 2002;420:860\u2013867. doi: 10.1038/nature01322.", "ArticleIdList": ["10.1038/nature01322", "PMC2803035", "12490959"]}, {"Citation": "D\u2019Archivio M., Filesi C., Di Benedetto R., Gargiulo R., Giovannini C., Masella R. Polyphenols, dietary sources and bioavailability. Ann. Ist. Super. Sanita. 2007;43:348\u2013361.", "ArticleIdList": ["18209268"]}, {"Citation": "Jacobs D., Gaudier E., van Duynhoven J., Vaughan E. Non-Digestible Food Ingredients, Colonic Microbiota and the Impact on Gut Health and Immunity: A Role for Metabolomics. Curr. Drug Metab. 2009;10:41\u201354. doi: 10.2174/138920009787048383.", "ArticleIdList": ["10.2174/138920009787048383", "19149512"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "5", "Day": "29"}, {"Year": "2023", "Month": "6", "Day": "21"}, {"Year": "2023", "Month": "6", "Day": "28"}, {"Year": "2023", "Month": "7", "Day": "17", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "14", "Hour": "13", "Minute": "7"}, {"Year": "2023", "Month": "7", "Day": "14", "Hour": "1", "Minute": "20"}, {"Year": "2023", "Month": "7", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["37446872", "PMC10343400", "10.3390/molecules28135210", "molecules28135210"]}}], "PubmedBookArticle": []}